Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
- Study Title
- A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDermג„¢ System in Adults With GH-Deficiency
- Teva Identifier
- GH-VD-102
- ClinicalTrials.gov Identifier
- NCT00455260
- Study Status
- Completed
- Trial Condition(s)
- Growth Hormone Deficiency
- Interventions
- Drug: hGH-ViaDermג„¢ System (hGH or somatropin) | Device: hGH-ViaDermג„¢ System
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 20 Years to 60 Years
- Trial Duration
- 04/01/2007 - 01/00/1900
- Phase
- Phase 1
